Landsberg Bennett & Dubbaneh’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$571K Sell
7,012
-247
-3% -$18.8K 0.07% 165
2021
Q2
$560K Sell
7,259
-54,029
-88% -$4.02M 0.07% 164
2021
Q1
$4.51M Buy
61,288
+680
+1% +$50.2K 0.65% 40
2020
Q4
$4.73M Buy
60,608
+614
+1% +$47K 0.72% 34
2020
Q3
$4.69M Sell
59,994
-4,464
-7% -$350K 0.82% 32
2020
Q2
$4.68M Sell
64,458
-1,984
-3% -$149K 0.97% 22
2020
Q1
$4.87M Buy
66,442
+18,825
+40% +$1.48M 1.36% 16
2019
Q4
$4.14M Buy
47,617
+380
+0.8% +$31.2K 0.97% 26
2019
Q3
$3.74M Buy
47,237
+134
+0.3% +$10.7K 1.01% 26
2019
Q2
$3.81M Buy
47,103
+1,573
+3% +$120K 1% 30
2019
Q1
$3.61M Buy
45,530
+638
+1% +$47.7K 0.85% 33
2018
Q4
$3.27M Buy
+44,892
New +$3.17M 1.26% 14

Other funds holding MRK

Landsberg Bennett & Dubbaneh's MRK Position: Q3 2021 in Review

Landsberg Bennett & Dubbaneh reduced its Merck (MRK) stake by 3.4% in Q3 2021, selling an estimated $18.8K and leaving 7,012 shares worth $571K. The position accounts for 0.07% of the portfolio, ranked #165.

Landsberg Bennett & Dubbaneh first reported a position in MRK in Q4 2018 and has held it in 12 quarters since. The position peaked at $4.87M in Q1 2020. 2,648 funds tracked by Wall St. Rank hold MRK as of Q3 2021.

  • Landsberg Bennett & Dubbaneh held 7,012 shares of Merck worth $571K as of Q3 2021.
  • Landsberg Bennett & Dubbaneh sold 247 Merck shares in Q3 2021, an estimated $18.8K.
  • Merck made up 0.07% of Landsberg Bennett & Dubbaneh's portfolio in Q3 2021, its #165 holding.
  • Landsberg Bennett & Dubbaneh first reported a position in Merck in Q4 2018 and has held it in 12 quarters since.
  • Landsberg Bennett & Dubbaneh's Merck position peaked at $4.87M in Q1 2020.
  • 2,648 funds tracked by Wall St. Rank held Merck as of Q3 2021.

Based on Landsberg Bennett & Dubbaneh's 13F filing for Q3 2021, filed 29 Oct 2021.